1
|
Vinding MC, Eriksson A, Comarovschii I, Waldthaler J, Manting CL, Oostenveld R, Ingvar M, Svenningsson P, Lundqvist D. The Swedish National Facility for Magnetoencephalography Parkinson's disease dataset. Sci Data 2024; 11:150. [PMID: 38296972 PMCID: PMC10830455 DOI: 10.1038/s41597-024-02987-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Accepted: 01/18/2024] [Indexed: 02/02/2024] Open
Abstract
Parkinson's disease (PD) is characterised by a loss of dopamine and dopaminergic cells. The consequences hereof are widespread network disturbances in brain function. It is an ongoing topic of investigation how the disease-related changes in brain function manifest in PD relate to clinical symptoms. We present The Swedish National Facility for Magnetoencephalography Parkinson's Disease Dataset (NatMEG-PD) as an Open Science contribution to identify the functional neural signatures of Parkinson's disease and contribute to diagnosis and treatment. The dataset contains whole-head magnetoencephalographic (MEG) recordings from 66 well-characterised PD patients on their regular dose of dopamine replacement therapy and 68 age- and sex-matched healthy controls. NatMEG-PD contains three-minute eyes-closed resting-state MEG, MEG during an active movement task, and MEG during passive movements. The data includes anonymised MRI for source analysis and clinical scores. MEG data is rich in nature and can be used to explore numerous functional features. By sharing these data, we hope other researchers will contribute to advancing our understanding of the relationship between brain activity and disease state or symptoms.
Collapse
Affiliation(s)
- Mikkel C Vinding
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark.
| | - Allison Eriksson
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
| | - Igori Comarovschii
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Josefine Waldthaler
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Department of Neurology, University Hospital Marburg, Marburg, Germany
| | - Cassia Low Manting
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
- McGovern Institute of Brain Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
| | - Robert Oostenveld
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands
| | - Martin Ingvar
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Per Svenningsson
- Section of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Daniel Lundqvist
- NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|